Amyntas Pharma Private Limited - Company Profile

It is a pharma private limited company based in Vaijapur, Maharashtra, India, established in 2017.
2017 Vaijapur, Maharashtra, India Active
Last Updated:
Access Report
About Amyntas Pharma Private Limited

Amyntas Pharma Private Limited, a active private limited company, was established on 14 February 2017 in Vaijapur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U33302MH2017PTC291193. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Apoorva Amar Shedge (Director), Harshal Chandrakant Patil (Director), Sajjadali Riyasatali Syed (Director). Past directors included Faiza Kadarali Sayed, Kadarali Riyasatali Sayyed, Riyastali Azgarali Syed. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H. No.873, Kazi Galli,, Vaijapur, Maharashtra, 423701.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33302MH2017PTC291193

  • Registration Number

    291193

  • Incorporation Date

    14 February 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** -27.27%
  • Ebitda **** -27.27%
  • Net Worth -13.49%
  • Total Assets -8.89%
Company report

Amyntas Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Amyntas Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Amyntas Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Apoorva Amar Shedge Director 19 Sep 2024 Current
Harshal Chandrakant Patil Director 19 Sep 2024 Current
Sajjadali Riyasatali Syed Director 19 Sep 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Director 15 Nov 2022 Past
Pramod Abcsdd Director 15 Nov 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Amyntas Pharma.

Amyntas Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 27.27% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.49%.

Amyntas Pharma revenue growth over time
Amyntas Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -8.89%
*******
*******
*******
*******
Profit or Loss
*******
 -27.27%
*******
*******
*******
*******
Net Worth
*******
 -13.49%
*******
*******
*******
*******
EBITDA
*******
 -27.27%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Amyntas Pharma?

In 2020, Amyntas Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Amyntas Pharma?

Unlock and access historical data on people associated with Amyntas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Amyntas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amyntas Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Amyntas Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Amyntas Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Amyntas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    The activity Apoorva Amar Shedge was appointed as a Director was appointed as a Director on 19 Sep 2024 & has been associated with this company since 1 year 4 months . was completed.

  • Director Appointment

    Harshal Chandrakant Patil was appointed as a Director was appointed as a Director on 19 Sep 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.

  • Director Appointment

    Progress on Sajjadali Riyasatali Syed was appointed as a Director was appointed as a Director on 19 Sep 2024 & has been associated with this company since 1 year 4 months . was documented.

  • Company Incorporation

    The activity Amyntas Pharma Private Limited was registered on 14 Feb 2017 with Roc Mumbai & aged 8 years 11 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Amyntas Pharma Private Limited?

The CIN of Amyntas Pharma Private Limited is U33302MH2017PTC291193.

Where is Amyntas Pharma Private Limited headquartered?

Amyntas Pharma Private Limited is headquartered at H. No.873, Kazi Galli,, Vaijapur, Maharashtra, 423701.

When was Amyntas Pharma Private Limited incorporated?

Amyntas Pharma Private Limited was incorporated on 14 February 2017.

Who are the current directors of Amyntas Pharma Private Limited?

The current directors of Amyntas Pharma Private Limited are

What is the primary industry of Amyntas Pharma Private Limited?

The primary industry of Amyntas Pharma Private Limited is Pharma.

Is Amyntas Pharma Private Limited a listed company?

Amyntas Pharma Private Limited is unlisted.

What is the capital structure of Amyntas Pharma Private Limited?

The authorized capital of Amyntas Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Amyntas Pharma Private Limited?

The compliance status of Amyntas Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available